MYD88 mutation and management of Waldenstroms Macroglobulinemia

MYD88 mutation and management of Waldenstroms Macroglobulinemia

ScrippsHealth

4 years
266 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Morie A. Gertz, MD of Mayo Clinic discusses MYD88 mutation and management of Waldenstroms Macroglobulinemia at Scripps Health 36th Annual Conference: Clinical Hematology and Oncology in San Diego.
Up Next Autoplay